Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1992;82(4):317-22.
doi: 10.1007/BF00161019.

Field loss after pan retinal photocoagulation with diode and argon lasers

Affiliations
Clinical Trial

Field loss after pan retinal photocoagulation with diode and argon lasers

S Buckley et al. Doc Ophthalmol. 1992.

Abstract

Argon and diode laser pan retinal photocoagulation are used in diabetic proliferative retinopathy. This is a prospective study of the effects of each laser type on peripheral field loss. It shows that diabetics have significantly reduced peripheral field prior to laser compared to normals (p = 0.006). With identical pan retinal photocoagulation with either argon or diode laser there is no difference in field loss.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Ophthalmology. 1978 Jan;85(1):82-106 - PubMed
    1. Acta Ophthalmol (Copenh). 1990 Dec;68(6):681-6 - PubMed
    1. Invest Ophthalmol Vis Sci. 1989 Jul;30(7):1504-10 - PubMed
    1. Eye (Lond). 1989;3 ( Pt 5):516-27 - PubMed
    1. Acta Ophthalmol (Copenh). 1989 Oct;67(5):537-45 - PubMed

LinkOut - more resources